Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node-positive bladder cancer: Results of a prospective study

被引：0
|
作者：
Lyu, Q. [1 ]
Yang, X. [1 ]
Cao, Q. [1 ]
Zhuang, J. [1 ]
机构：
[1] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Peoples R China
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0904
引用
收藏
页码：S1957 / S1957
页数：1
相关论文
共 50 条
  • [31] THE ROLE OF EXTENDED VERSUS STANDARD LYMPHADENECTOMY LYMPH NODE DISSECTION IN CLINICALLY LYMPH NODE-POSITIVE BLADDER CANCER
    Von Deimling, Markus
    Mari, Andrea
    Bianchi, Alberto
    Maas, Moritz
    Pichler, Renate
    Vetterlein, Malte W.
    Del Giudice, Francesco
    Tully, Karl H.
    Afferi, Luca
    Moschini, Marco
    Laukhtina, Ekaterina
    Rink, Michael
    Shariat, Shahrokh F.
    Pradere, Benjamin
    JOURNAL OF UROLOGY, 2023, 209 : E640 - E640
  • [32] Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
    Narayan, Vivek
    Mamtani, Ronac
    Keefe, Stephen
    Guzzo, Thomas
    Malkowicz, S. Bruce
    Vaughn, David J.
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1084 - 1091
  • [33] Clinical outcome after cystectomy in patients with lymph node-positive bladder cancer
    Nagele, Udo
    Anastasiadis, Aristotelis G.
    Merseburger, Axel S.
    Sievert, Karl-Dietrich
    Stenzl, Arnulf
    Kuczyk, Markus
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 871 - 876
  • [34] The role of extended versus standard lymphadenectomy lymph node dissection in clinically lymph node-positive bladder cancer
    von Deimling, M.
    Mari, A.
    Bianchi, A.
    Maas, M.
    Pichler, R.
    Vetterlein, M.
    Del Giudice, F.
    Tully, K. H.
    Afferi, L.
    Moschini, M.
    Laukhtina, E.
    Rink, M.
    Shariat, S. F.
    Pradere, B.
    EUROPEAN UROLOGY, 2023, 83
  • [35] Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
    Ja Hyeon Ku
    Minyong Kang
    Hyung Suk Kim
    Chang Wook Jeong
    Cheol Kwak
    Hyeon Hoe Kim
    BMC Cancer, 15
  • [36] Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
    Ku, Ja Hyeon
    Kang, Minyong
    Kim, Hyung Suk
    Jeong, Chang Wook
    Kwak, Cheol
    Kim, Hyeon Hoe
    BMC CANCER, 2015, 15
  • [37] Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study
    Morency, Dominique
    Dumitra, Sinziana
    Parvez, Elena
    Martel, Karyne
    Basik, Mark
    Robidoux, Andre
    Poirier, Brigitte
    Holloway, Claire M. B.
    Gaboury, Louis
    Sideris, Lucas
    Meterissian, Sarkis
    Boileau, Jean-Francois
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (13) : 4337 - 4345
  • [38] Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis
    Mofid, Bahram
    Razzaghdoust, Abolfazl
    Ghajari, Mahdi
    Basiri, Abbas
    Fattahi, Mohammad-Reza
    Houshyari, Mohammad
    Jafari, Anya
    Taghizadeh-Hesary, Farzad
    UROLOGY JOURNAL, 2022, 19 (05) : 371 - 378
  • [39] Outcomes of Sentinel Lymph Node Biopsy for Patients With Node-positive Breast Cancer Treated With Neoadjuvant Chemotherapy
    Cipolla, Calogero
    Vieni, Salvatore
    D'agati, Eleonora
    Grassi, Nello
    Genova, Pietro
    Graceffa, Giuseppa
    Vigneri, Paolo
    Gebbia, Vittorio
    Valerio, Maria rosaria
    ANTICANCER RESEARCH, 2023, 43 (10) : 4643 - 4649
  • [40] Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
    Piltin, Mara A.
    Hoskin, Tanya L.
    Day, Courtney N.
    Davis, John, Jr.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (12) : 4795 - 4801
12345